Search results

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

ANSTO is expanding its global connections, with the nandin Innovation Centre joining an international network created to increase cross industry collaboration and co-creation.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

Pioneering work on materials for energy production, such as lithium ion batteries, has made ANSTO a centre of specialist capabilities and expertise.

The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.